Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells

Biochemical and Biophysical Research Communications

Volumn 415, Issue 2, 2011, Pages 319-324

  Raufman, Jean Pierre ^a   Cheng, Kunrong ^a   Saxena, Neeraj ^a   Chahdi, Ahmed ^a   Belo, Angelica ^a   Khurana, Sandeep ^a   Xie, Guofeng ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Bile acids; Cell invasion; Cell migration; Colon cancer; Matrix metalloproteinases

Indexed keywords

ACETYLCHOLINE; ATROPINE; INTERSTITIAL COLLAGENASE; MATRIGEL; MUSCARINIC AGENT; NEUTRALIZING ANTIBODY; TAURODEOXYCHOLIC ACID;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

ACETYLCHOLINE; CELL MOVEMENT; COLONIC NEOPLASMS; HT29 CELLS; HUMANS; MATRIX METALLOPROTEINASE 1; MUSCARINIC AGONISTS; NEOPLASM INVASIVENESS; RECEPTORS, MUSCARINIC; TAURODEOXYCHOLIC ACID;

ANIMALIA; MAMMALIA;

EID: 84855882732     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.052     Document Type: Article

References (18)

1. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13:781-792.
2. Zucker S., Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 2004, 23:101-117.
3. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 1996, 2:461-462.
4. Baker E.A., Bergin F.G., Leaper D.J. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br. J. Surg. 2000, 87:1215-1221.
5. Sunami E., Tsuno N., Osada T., Saito S., Kitayama J., Tomozawa S., Tsuruo T., Shibata Y., Muto T., Nagawa H. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 2000, 5:108-114.
6. Cheng K., Zimniak P., Raufman J.P. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res. 2003, 63:6744-6750.
7. Cheng K., Raufman J.P. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem. Pharmacol. 2005, 70:1035-1047.
8. Cheng K., Samimi R., Xie G., Shant J., Drachenberg C., Wade M., Davis R.J., Nomikos G., Raufman J.P. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G591-G597.
9. Shant J., Cheng K., Marasa B.S., Wang J.Y., Raufman J.P. Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis. Exp. Cell Res. 2009, 315:432-450.
10. Raufman J.P., Samimi R., Shah N., Khurana S., Shant J., Drachenberg C., Xie G., Wess J., Cheng K. Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia. Cancer Res. 2008, 68:3573-3578.
11. Raufman J.P., Shant J., Xie G., Cheng K., Gao X.M., Shiu B., Shah N., Drachenberg C.B., Heath J., Wess J., Khurana S. Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice. Carcinogenesis 2011, 32:1396-1402.
12. Belo A., Cheng K., Chahdi A., Shant J., Xie G., Khurana S., Raufman J.P. Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G749-G760.
13. Xie G., Cheng K., Shant J., Raufman J.P. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G755-G763.
14. Markowitz S.D., Dawson D.M., Willis J., Willson J.K. Focus on colon cancer. Cancer Cell 2002, 1:233-236.
15. Saxena N.K., Sharma D., Ding X., Lin S., Marra F., Merlin D., Anania F.A. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007, 67:2497-2507.
16. Narisawa T., Magadia N.E., Weisburger J.H., Wynder E.L. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. J. Natl. Cancer Inst. 1974, 53:1093-1097.
17. Flynn C., Montrose D.C., Swank D.L., Nakanishi M., Ilsley J.N., Rosenberg D.W. Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Mol. Carcinog. 2007, 46:60-70.
18. Raufman J.P., Cheng K., Zimniak P. Activation of muscarinic receptor signaling by bile acids: physiological and medical implications. Dig. Dis. Sci. 2003, 48:1431-1444.